In conversation with... Shankar Siva

from Listen to The Lancet Oncology · host The Lancet

Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.

Episode metadata supplied by the publisher feed · Published Nov 28, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Shankar Siva

0:00 8:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 8 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on November 28, 2022.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!